featured
Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Patients With Metastatic TNBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and In Situ Virus Gene Therapy in Metastatic Triple Negative Breast Cancer
Clin. Cancer Res 2022 Jul 25;[EPub Ahead of Print], K Sun, Y Xu, L Zhang, P Niravath, J Darcourt, T Patel, BS Teh, AM Farach, C Guerrero, S Mathur, MA Sultenfuss, N Gupta, MR Schwartz, SL Haley, S Nair, X Li, TTA Nguyen, JD Butner, J Ensor, JA Mejia, Z Mei, EB Butler, SH Chen, EH Bernicker, JC ChangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.